F. Bolaños

Common pharmacological and physico-chemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells.

M. Hamon, M. Emerit, M. Miquel, 1990, Biochemical pharmacology.

Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact?

D. Hoyer, M. Hamon, L. Schechter, 1989, European journal of pharmacology.

Physicochemical Properties of Serotonin 5‐HT3 Binding Sites Solubilized from Membranes of NG 108‐15 Neuroblastoma‐Glioma Cells

M. Hamon, M. Emerit, M. Miquel, 1990, Journal of neurochemistry.

Determination of the molecular size of the 5-HT3 receptor binding site by radiation inactivation.

M. Hamon, M. Emerit, M. Miquel, 1989, European journal of pharmacology.

Expression of Dp71 in Müller glial cells: a comparison with utrophin- and dystrophin-associated proteins.

J. Sahel, A. Reichenbach, T. Pannicke, 2000, Investigative ophthalmology & visual science.

[3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies.

M. Hamon, D. Vergé, L. Schechter, 1991, European journal of pharmacology.

The main features of central 5-HT1 receptors.

L. Lanfumey, M. Hamon, S. El Mestikawy, 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

The Central 5‐HT1A Receptors: Pharmacological, Biochemical, Functional, and Regulatory Properties a

M. Hamon, M. Emerit, S. Mestikawy, 1990, Annals of the New York Academy of Sciences.

Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.

S. Haj-Dahmane, L. Lanfumey, M. Hamon, 1990, The Journal of pharmacology and experimental therapeutics.

Minaprine antagonises the serotonergic inhibitory effect of trifluoromethylphenylpiperazine (TFMPP) on acetylcholine release.

G. Fillion, F. Bolaños, 1989, European journal of pharmacology.